ETV6 and sarcoma: Five patients with ETV6-NTRK3 fusion-positive infantile sarcomas are all alive without disease for an average of 11.7 years (range: 6.0–17.4 years), but one case who had a huge sacrococcygeal mass was lost to follow-up.